# Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial

> **NCT05639322** · PHASE4 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 30 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **BEHAVIORAL:** Cognitive Behavioral Therapy
- **OTHER:** Ketamine + Cognitive Behavioral Therapy

## Key facts

- **NCT ID:** NCT05639322
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-12
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05639322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05639322, "Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05639322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*